Overview

This activity is modeled after an exam study guide.

The guide presents case-based questions that challenge you to consider the structural, functional, and clinical differences between biosimilar products and their reference drugs, as well as their potential clinical applications. Multiple choice questions allow you to test your knowledge and ability to apply current evidence to clinical scenarios.

Receive feedback on your answer choice and on how your peers collectively answer each question.

Confirm the optimal answer using the evidence-based rationale provided by our faculty.

Download the activity print version..

Content Areas

Manufacturing process

Approval basis

Pharmacoeconomic impact

Clinical implications

Target Audience

Rheumatologists, oncologists, dermatologists, gastroenterologists, nephrologists, pharmacists, and other clinicians who currently use or may consider using biosimilars in clinical practice.

This activity is supported by an independent educational grant from Pfizer.

Faculty

Edward Li, PharmD, MPHAssociate Professor
Department of Pharmacy Practice
University of New England College of Pharmacy
Portland, Maine

Leonard Calabrese, DOProfessor of Medicine, Cleveland Clinic College of Medicine
Case Western Researve University
Clinical Professor of Internal Medicine
Ohio University Heritage College of Osteopathic Medicine
Cleveland, Ohio

Leonard Calabrese, DOProfessor of Medicine, Cleveland Clinic College of Medicine
Case Western Researve University
Clinical Professor of Internal Medicine
Ohio University Heritage College of Osteopathic Medicine
Cleveland, Ohio

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of
2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The
Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned
ACPE Universal Program 0797-0000-17-061-H04-P. This program is designated for up to
2.00 contact hours (0.2 CEU) of continuing pharmacy education credit.

Disclosure Statement

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Additional Content Planners

John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from Pfizer.

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is
2.00 hours.

This activity was originally released on
July 07, 2017 and is eligible for credit through
July 06, 2018.

Our Policy on Privacy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/